- 2026-12-06
-
Single-cell screening of PARP inhibitor-induced malignant epithelial programs identifies an immune-visible prognostic axis in high-grade serous ovarian cancer
13:00-13:07
Room 504
Mini Oral
Speaker
-
A multi-omics and pharmacogenomic prioritization of a FANCD2/USP1-associated DNA repair program in ovarian cancer treatment response
13:49-13:56
Room 504
Mini Oral
Speaker


